Clinical Trial Update: Alanosine in Treating Patients With Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating alanosine in patients with several cancers (lung cancer, malignant mesothelioma, pancreatic cancer, and sarcoma) has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Malignant Mesothelioma
• Pancreatic Cancer
• Sarcoma

Drugs mentioned

• Alanosine (alanosine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer, Malignant Mesothelioma | Phase 2 | Status: COMPLETED